Tuesday, 6 January 2015

Epic Research Update : Abbott





Patent office sets aside earlier order granting patent to Abbott’s Humira: BS



One of Abbott’s key products, Humira is a rheumatoid arthritis drug



The pre-grant opposition was filed by Glenmark Pharmaceuticals



Real Time News & Trading Trends Keep Liking #EpicResearch



FacebookTwitterYouTubePinterestLinkedinGoogle+



For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH

0 comments:

Post a Comment

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Online Project management